The relationship between leukemia inhibitory factor and neurokinin receptors in a rat model of asthma

Zhonghua Jiehe he Huxi Zazhi

Volumn 28, Issue 12, 2005, Pages 820-824

  Lin, Min Juan ^a   Lao, Xue Jun ^a   Ma, Hong Ming ^a   Tang, Yan ^a  

^a JINAN UNIVERSITY   (China)

Author keywords

Asthma; Leukemia inhibitory factor; Neurogenic inflammation; Neurokinin

Indexed keywords

LEUKEMIA INHIBITORY FACTOR; NEUROKININ 1 RECEPTOR; NEUROKININ 2 RECEPTOR;

ANIMAL; ARTICLE; ASTHMA; DISEASE MODEL; LUNG; MALE; METABOLISM; RAT; WISTAR RAT;

ANIMALS; ASTHMA; DISEASE MODELS, ANIMAL; LEUKEMIA INHIBITORY FACTOR; LUNG; MALE; RATS; RATS, WISTAR; RECEPTORS, NEUROKININ-1; RECEPTORS, NEUROKININ-2;

EID: 33749531863     PISSN: 10010939     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Gadient RA, Patterson PH. Leukemia inhibitory factor, Interleukin 6, and other cytokines using the GP130 transducing receptor: roles in inflammation and injury. Stem Cells, 1999, 17:127-137.
2. Knight DA, Lydell CP, Zhou D, et al. Leukemia inhibitory factor (LIF) and LIF receptor in human lung. Distribution and regulation of LIF release. Am J Respir Cell Mol Biol, 1999, 20:834-841.
3. Viallard JF, Taupin JL, Ranchin V, et al. Analysis of leukemia inhibitory factor, type 1 and type 2 cytokine production in patients with eosinophilic fasciitis. J Rheumatol, 2001, 28:75-80.
4. Germonpre PR, Joos GF, Everaert E, et al. Characterization of neurogenic inflammation in the airways of two highly inbred rat strains. Am J Respir Crit Care Med, 1995, 152(6 Pt 1):1796-1804.
5. Olgart Hoglund C, Frossard N. Nerve growth factor and asthma. Pulm Pharmacol Ther, 2002, 15:51-60.
6. Hu C, Wedde-Beer K, Auais A, et al. Nerve growth factor and nerve growth factor receptors in respiratory syncytial virus-infected lungs. Am J Physiol Lung Cell Mol Physiol, 2002, 283:L494-L502.
7. Gollner G, Bug G, Rupilius B, et al. Regulatory elements of the leukaemia inhibitory factor (LIF) promoter in murine bone marrow stromal cells. Cytokine, 1999, 11:656-663.
8. Knight DA, D'Aprile AC, Spalding LJ, et al. Leukaemia inhibitory factor (LIF) upregulates excitatory non-adrenergic non-cholinergic and maintains cholinergic neural function in tracheal explants. Br J Pharmacol, 2000, 130:975-979.
9. Knight D. Leukaemia inhibitory factor (LIF): a cytokine of emerging importance in chronic airway inflammation. Pulm Pharmacol Ther, 2001, 14:169-176.
10. Zheng X, Knight DA, Zhou D, et al. Leukemia inhibitory factor is synthesized and released by human eosinophils and modulates activation state and chemotaxis. J Allergy Clin Immunol, 1999, 104: 136-144.